Primary Record
BNC105p
Note: Only for scientific research or as raw materials for production.
- In stock
- 2,977 g
- Purity
- 98.7 %
- CAS
- 945771-96-0
Compound Identifiers & Properties
- CAS
- 945771-96-0
- PubChem CID
- 16678086
- SMILES
- CC1=C(C2=C(O1)C(=C(C=C2)OC)OP(=O)([O-])[O-])C(=O)C3=CC(=C(C(=C3)OC)OC)OC.[Na+].[Na+]
- Canonical SMILES
- COc1cc(C(=O)c2c(C)oc3c(OP(=O)([O-])[O-])c(OC)ccc23)cc(OC)c1OC.[Na+].[Na+]
Names & Synonyms
- BNC105p
- BNC-105p
- starbld0045574
- RefChem:120826
- 945771-96-0
- D01AZP
- VDAs (cancer), Bionomics
- BNC 105P
- UNII-E3052198GM
- BNC105P [WHO-DD]
- orb1741208
- SCHEMBL1459413
- CHEMBL1823160
- E3052198GM
- 945771-96-0 (sodium)
- BNC-105
- EX-A3038
- IL-0035
- IL-0049
- SB17279
- FB176471
- VASCULAR DISRUPTING AGENT BNC105P
- Combretastatin A4 analogs (cancer), Bionomics
- Vascular targeting agents (cancer), Bionomics
- Vascular disruption agents (cancer), Bionomics
- Z-3125
- Methanone, (6-methoxy-2-methyl-7-(phosphonooxy)-3-benzofuranyl)(3,4,5-trimethoxyphenyl)-, sodium salt (1:2)
- sodium 6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzofuran-7-yl phosphate
- Q27276800
- disodium;[6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)-1-benzofuran-7-yl] phosphate
- 945772-45-2